Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $894.85 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $173.29 | 2 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $166.56 | 2 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $126.00 | 1 | $0 (2023) |
| The Binding Site Inc. | $106.74 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $97.67 | 1 | $0 (2019) |
| Gilead Sciences, Inc. | $93.24 | 1 | $0 (2019) |
| Novo Nordisk Inc | $81.41 | 2 | $0 (2022) |
| Phadia US Inc. | $49.94 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $232.74 | 2 | Regeneron Healthcare Solutions, Inc. ($126.00) |
| 2022 | $42.60 | 1 | Novo Nordisk Inc ($42.60) |
| 2019 | $279.66 | 4 | Novartis Pharmaceuticals Corporation ($97.67) |
| 2018 | $93.97 | 1 | Amgen Inc. ($93.97) |
| 2017 | $245.88 | 3 | Teva Pharmaceuticals USA, Inc. ($166.56) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/21/2023 | The Binding Site Inc. | Freelite (Device) | Food and Beverage | Cash or cash equivalent | $106.74 | General |
| Category: Immunology | ||||||
| 03/22/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $126.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/28/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $42.60 | General |
| Category: Diabetes | ||||||
| 11/09/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $38.81 | General |
| 09/10/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $97.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/11/2019 | Gilead Sciences, Inc. | Truvada (Drug) | Food and Beverage | In-kind items and services | $93.24 | General |
| Category: HIV | ||||||
| 03/12/2019 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $49.94 | General |
| Category: Allergy/Immunology | ||||||
| 03/13/2018 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $93.97 | General |
| 09/11/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Food and Beverage | In-kind items and services | $83.28 | General |
| Category: Central Nervous System | ||||||
| 09/11/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Food and Beverage | In-kind items and services | $83.28 | General |
| Category: Central Nervous System | ||||||
| 03/21/2017 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $79.32 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 46 | 62 | $13,400 | $4,702 |
| 2022 | 1 | 21 | 35 | $7,000 | $2,465 |
| 2021 | 1 | 38 | 111 | $18,130 | $7,722 |
| 2020 | 2 | 73 | 137 | $21,615 | $8,849 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 42 | $8,400 | $2,981 | 35.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $5,000 | $1,720 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 35 | $7,000 | $2,465 | 35.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 111 | $18,130 | $7,722 | 42.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 48 | 112 | $16,240 | $6,796 | 41.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 25 | 25 | $5,375 | $2,053 | 38.2% |
About Dr. Jeffrey Soffa, D.O
Dr. Jeffrey Soffa, D.O is a Family Medicine healthcare provider based in Livonia, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588604854.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Soffa, D.O has received a total of $894.85 in payments from pharmaceutical and medical device companies, with $232.74 received in 2023. These payments were reported across 11 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($894.85).
As a Medicare-enrolled provider, Soffa has provided services to 178 Medicare beneficiaries, totaling 345 services with total Medicare billing of $23,737. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Livonia, MI
- Active Since 06/07/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1588604854
Products in Payments
- COPAXONE (Drug) $166.56
- DUPIXENT (Biological) $126.00
- Freelite (Device) $106.74
- ENTRESTO (Drug) $97.67
- Truvada (Drug) $93.24
- ImmunoCAP (Device) $49.94
- Rybelsus (Drug) $42.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Livonia
Martin Erickson, D.o, D.O
Family Medicine — Payments: $13,875
J.adam Kellman, D.o, D.O
Family Medicine — Payments: $13,031
Paul Jackson, D.o, D.O
Family Medicine — Payments: $12,900
Thomas Selznick, D.o, D.O
Family Medicine — Payments: $12,698
William Penn, D.o, D.O
Family Medicine — Payments: $9,628
Dr. Keith Tobin, D.o, D.O
Family Medicine — Payments: $7,899